EUVIMEDEUVIMED entdecken
Open Access

Atf3 controls transitioning in female mitochondrial cardiomyopathy as identified by spatial and single-cell transcriptomics

Tasneem Qaqorh iD, Yusuke Takahashi, Kohei Sameshima iD, Kentaro Otani iD, Issei Yazawa, Yuya Nishida iD, Kohei Tonai iD, Yoshitaka Fujihara iD, Mizuki Honda iD, Shinya Oki iD, Yasuyuki Ohkawa iD, David R Thorburn iD und 18 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adq1575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Tasneem Qaqorh und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Activating Transcription Factor 3, Single-Cell Analysis, Transcriptome, Cardiomyopathies. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative phosphorylation defects result in now intractable mitochondrial diseases (MD) with cardiac involvement markedly affecting prognosis. The mechanisms underlying the transition from compensation to dysfunction in response to metabolic deficiency remain unclear. Here, we used spatially resolved transcriptomics and single-nucleus RNA sequencing (snRNA-seq) on the heart of a patient with mitochondrial cardiomyopathy (MCM), combined with an MCM mouse model with cardiac-specific Ndufs6 knockdown (FS6KD). Cardiomyocytes demonstrated the most heterogeneous expression landscape among cell types caused by metabolic perturbation, and pseudotime trajectory analysis revealed dynamic cellular states transitioning from compensation to severe compromise. This progression coincided with the transient up-regulation of a transcription factor, ATF3 . Genetic ablation of Atf3 in FS6KD corroborated its pivotal role, effectively delaying cardiomyopathy progression in a female-specific manner. Our findings highlight a fate-determining role of ATF3 in female MCM progression and that the latest transcriptomic analysis will help decipher the mechanisms underlying MD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activating Transcription Factor 3Single-Cell AnalysisTranscriptomeCardiomyopathiesMitochondrial DiseasesFemaleAnimalsMiceHumansGene Expression ProfilingMyocytes, CardiacDisease Models, AnimalMitochondria

Substanzen

Activating Transcription Factor 3ATF3 protein, humanAtf3 protein, mouse

Autor:innen und Institutionen

  • Department of Molecular Pharmacology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
  • Department of Medical Biochemistry, Osaka University Graduate School of Frontier Biosciences, Suita, Osaka, Japan.
  • Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
  • Department of Drug Discovery Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Division of Transcriptomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
  • Murdoch Children's Research Institute, Royal Children's Hospital, and University of Melbourne, Department of Paediatrics, Parkville, Victoria, Australia.

ORCID-Profile: Tasneem Qaqorh, Kohei Sameshima, Kentaro Otani, Yuya Nishida, Kohei Tonai, Yoshitaka Fujihara, Mizuki Honda, Shinya Oki, Yasuyuki Ohkawa, David R Thorburn, Ann E Frazier, Yoshihiko Ikeda, Heima Sakaguchi, Takuya Watanabe, Norihide Fukushima, Yasumasa Tsukamoto, Naomasa Makita, Osamu Yamaguchi, Kei Murayama, Akira Ohtake, Yasushi Okazaki, Hisakazu Kato, Yasunori Shintani

Zitieren

APA

Qaqorh, T., Takahashi, Y., Sameshima, K., Otani, K., Yazawa, I., Nishida, Y., Tonai, K., Fujihara, Y., Honda, M., Oki, S., Ohkawa, Y., Thorburn, D. R., Frazier, A. E., Takeda, A., Ikeda, Y., Sakaguchi, H., Watanabe, T., Fukushima, N., Tsukamoto, Y., …, & Shintani, Y. (2025). Atf3 controls transitioning in female mitochondrial cardiomyopathy as identified by spatial and single-cell transcriptomics. Science Advances. https://doi.org/10.1126/sciadv.adq1575

Vancouver

Qaqorh T, Takahashi Y, Sameshima K, Otani K, Yazawa I, Nishida Y, et al. Atf3 controls transitioning in female mitochondrial cardiomyopathy as identified by spatial and single-cell transcriptomics. Science Advances. 2025. doi:10.1126/sciadv.adq1575

BibTeX
@article{Qaqorh2025,
  author = {Qaqorh, Tasneem and Takahashi, Yusuke and Sameshima, Kohei and Otani, Kentaro and Yazawa, Issei and Nishida, Yuya and Tonai, Kohei and Fujihara, Yoshitaka and Honda, Mizuki and Oki, Shinya and Ohkawa, Yasuyuki and Thorburn, David R and Frazier, Ann E and Takeda, Atsuhito and Ikeda, Yoshihiko and Sakaguchi, Heima and Watanabe, Takuya and Fukushima, Norihide and Tsukamoto, Yasumasa and Makita, Naomasa and Yamaguchi, Osamu and Murayama, Kei and Ohtake, Akira and Okazaki, Yasushi and Kimura, Takanari and Kato, Hisakazu and Inoue, Hijiri and Matsuoka, Ken and Takashima, Seiji and Shintani, Yasunori},
  title = {Atf3 controls transitioning in female mitochondrial cardiomyopathy as identified by spatial and single-cell transcriptomics},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adq1575}
}
Kostenlos starten →